Cobalt-57 bleomycin for imaging head and neck tumors

Journal Article · Tue May 01 04:00:00 EDT 1979 · Cancer; (United States)

DOI:https://doi.org/10.1002/1097-0142(197905)43:5<1652::AID-CNCR2820430514>3.0.CO;2-I· OSTI ID:5967039

Woolfenden, J M; Alberts, D S; Hall, J N; Patton, D D

Cobalt-57 bleomycin imaging was performed in 11 patients with a history of head and neck cancer. Clinical and scan findings concurred on the presence and extent of tumor in 9 patients (82%); tumor was present in 7 and absent in 2 of the 9. In 2 patients (18%) the scan demonstrated tumor in the neck but failed to show metastatic sites. Cobalt-57 bleomycin images were of good technical quality, with remarkably low background activity at 24 hours after administration. Cobalt-57 bleomycin imaging appears to be a promising technique for evaluating patients with head and neck tumors.

• Research Organization: Univ. of Arizona Health Sciences Center, Tucson
• OSTI ID: 5967039
• Journal Information: Cancer; (United States), Journal Name: Cancer; (United States) Vol. 43:5; ISSN CANCA
• Country of Publication: United States
• Language: English

Related Subjects

550601* -- Medicine-- Unsealed Radionuclides in Diagnostics
560171 -- Radiation Effects-- Nuclide Kinetics &amp; Toxicology-- Man-- (-1987)
62 RADIOLOGY AND NUCLEAR MEDICINE
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
ANTIBIOTICS
ANTIMITOTIC DRUGS
BETA DECAY RADIOISOTOPES
BIOLOGICAL LOCALIZATION
BLEOMYCIN
BODY
BODY AREAS
COBALT 57
COBALT ISOTOPES
COUNTING TECHNIQUES
DATA
DATA FORMS
DAYS LIVING RADIOISOTOPES
DIAGNOSIS
DIAGNOSTIC TECHNIQUES
DISEASES
DRUGS
ELECTRON CAPTURE RADIOISOTOPES
EXPERIMENTAL DATA
HEAD
INFORMATION
INTERMEDIATE MASS NUCLEI
ISOLATED VALUES
ISOTOPES
LABELLED COMPOUNDS
NECK
NEOPLASMS
NUCLEI
NUMERICAL DATA
ODD-EVEN NUCLEI
PATIENTS
RADIOACTIVE MATERIALS
RADIOISOTOPE SCANNING
RADIOISOTOPES
RADIOPHARMACEUTICALS
SCINTISCANNING